Document is current
Any future updates will be listed below
-
Authors
Yang, Xiao
Dai, Yu-Hong
Peng, Hui
Zhang, Ming-Sheng
Fu, Qiang
Liu, Shun-Fang
Sun, Li
Zou, Yan-Mei
Xu, Hai-Sheng
Qiu, Ping
Qiu, Hong
Huang, Qiao
Cheng, Heng-hui
Zhuang, Liang
-
Funding
Funding for this research was provided by:
Beijing Xisike Clinical Oncology Research Foundation (No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074, No. Y-SY201901-0074)
the Natural Science Foundation of Hubei Province (2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331, 2021CFB331)
the Fund for Hepatobiliary and Pancreatic Malignant Tumours of the Hubei Chen Xiaoping Science and Technology Development Foundation (CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344, CXPJJH12000001-2020344)
- License Information
-
More Information
Article History
Received: 4 January 2025
Accepted: 24 June 2025
First Online: 16 August 2025
Declarations
:
: This study has obtained informed consent from participants. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This study was registered with the Ethics Committee of Registered Clinical Trials in China and has undergone ethical review under the ethical review symbol: ChiECRCT-20180167.
: All authors have intellectually contributed to this manuscript and provided consent for submission and publication.
: The authors declare no competing interests.
